Literature DB >> 22785213

The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation.

Debolina Ray1, Keith R Murphy, Susannah Gal.   

Abstract

Stress treatment generally causes the post-translational modification and accumulation of the p53 protein, although the role of these aspects has not been always understood in relation to this protein's tumor suppressor activity. We analyzed these attributes of p53 in eight different breast cancer cell lines, with either wild-type or mutant p53 protein, in response to oxidative stress. We found that the wild-type p53 protein from MCF-7 and ZR-75-1 cells binds with different affinity to 12 gene sequences covering several pathways regulated by p53. Treatment of MCF-7 cells with H2O2 caused an increase in this binding affinity while this same treatment of ZR-75-1 cells caused the p53 protein to lose binding affinity to several genes. The mutant p53 proteins from all cell lines had minimal to weak binding to these sequences even after treatment with H2O2. The p53 protein from the ZR-75-1 cells and three cell lines with mutant p53 showed serine 15 phosphorylated protein, but we found no correlation between that modification and the levels or localization of this protein although DNA binding affinity of wild-type protein might be affected by this modification. From this and other work, it appears that the mutation status of the TP53 gene alone cannot predict the activity of this tumor suppressor since cell lines with the same genetic information do not show the same properties of this protein.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785213      PMCID: PMC3414409          DOI: 10.4161/cbt.20835

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  48 in total

1.  Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis.

Authors:  B Formby; T S Wiley
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  BRCA1 physically associates with p53 and stimulates its transcriptional activity.

Authors:  H Zhang; K Somasundaram; Y Peng; H Tian; H Zhang; D Bi; B L Weber; W S El-Deiry
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

3.  JNK targets p53 ubiquitination and degradation in nonstressed cells.

Authors:  S Y Fuchs; V Adler; T Buschmann; Z Yin; X Wu; S N Jones; Z Ronai
Journal:  Genes Dev       Date:  1998-09-01       Impact factor: 11.361

4.  Intracellular localization of p53 tumor suppressor protein in gamma-irradiated cells is cell cycle regulated and determined by the nucleus.

Authors:  E A Komarova; C R Zelnick; D Chin; M Zeremski; A S Gleiberman; S S Bacus; A V Gudkov
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

5.  Cadmium induces phosphorylation of p53 at serine 15 in MCF-7 cells.

Authors:  M Matsuoka; H Igisu
Journal:  Biochem Biophys Res Commun       Date:  2001-04-20       Impact factor: 3.575

6.  Blockage of NF-kappaB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells.

Authors:  Luiz F Zerbini; Yihong Wang; Ricardo G Correa; Je-Yoel Cho; Towia A Libermann
Journal:  Cell Cycle       Date:  2005-09-24       Impact factor: 4.534

7.  Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.

Authors:  E Sugikawa; N Yazaki; S Tsunoda; N Nakanishi; M Ohashi
Journal:  Biochem Biophys Res Commun       Date:  1999-08-02       Impact factor: 3.575

8.  Phosphorylation of p53 serine 15 increases interaction with CBP.

Authors:  P F Lambert; F Kashanchi; M F Radonovich; R Shiekhattar; J N Brady
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

9.  p53 accumulates but is functionally impaired when DNA synthesis is blocked.

Authors:  V Gottifredi; S Shieh; Y Taya; C Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

10.  Mutant p53 proteins bind DNA in a DNA structure-selective mode.

Authors:  Thomas Göhler; Stefan Jäger; Gabriele Warnecke; Hideyo Yasuda; Ella Kim; Wolfgang Deppert
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

View more
  9 in total

1.  p53 Loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.

Authors:  Bhushan Thakur; Pritha Ray
Journal:  Mol Oncol       Date:  2016-06-29       Impact factor: 6.603

Review 2.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

3.  Partial Protection of PC12 Cells from Cellular Stress by Low-Dose Sodium Nitroprusside Pre-treatment.

Authors:  Judit Varga; Judit Bátor; Gergő Nádasdi; Zita Árvai; Renáta Schipp; József Szeberényi
Journal:  Cell Mol Neurobiol       Date:  2015-12-01       Impact factor: 5.046

4.  Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis.

Authors:  Andrea Arenz; Frank Ziemann; Christina Mayer; Andrea Wittig; Kirstin Dreffke; Stefanie Preising; Steffen Wagner; Jens-Peter Klussmann; Rita Engenhart-Cabillic; Claus Wittekindt
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

5.  Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells.

Authors:  Matthew T Balmer; Ryan D Katz; Si Liao; James S Goodwine; Susannah Gal
Journal:  Cancer Biol Ther       Date:  2014-05-06       Impact factor: 4.742

6.  Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy.

Authors:  Naveen Kumar; Masoom Raza; Seema Sehrawat
Journal:  Mol Cell Biochem       Date:  2021-07-29       Impact factor: 3.396

7.  Anti-apoptotic NF-κB and "gain of function" mutp53 in concert act pro-apoptotic in response to UVB+IL-1 via enhanced TNF production.

Authors:  Ines Müller; Stefan Beissert; Dagmar Kulms
Journal:  J Invest Dermatol       Date:  2014-11-07       Impact factor: 8.551

8.  Glucose-dependent GPER1 expression modulates tamoxifen-induced IGFBP-1 accumulation.

Authors:  Yan Zheng; Kevin D Houston
Journal:  J Mol Endocrinol       Date:  2019-08-01       Impact factor: 5.098

Review 9.  Regulators of Oncogenic Mutant TP53 Gain of Function.

Authors:  Satomi Yamamoto; Tomoo Iwakuma
Journal:  Cancers (Basel)       Date:  2018-12-20       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.